NK Cell Therapy: How It Works, Key Advantages, and 2026 Clinical Progress
NK cell therapy is redefining cancer immunotherapy by combining potent tumor-killing power with a safer side effect profile than traditional CAR-T treatments. Unlike T cells, natural killer cells can detect and destroy tumor cells within 24–48 hours without prior antigen sensitization. This comprehensive guide covers the biology, therapeutic modalities, and cutting-edge 2026 clinical data shaping the field.
Biotechnology Engineering: How It Repairs the Human Body
Biotechnology engineering is transforming how the human body heals—guiding each phase of wound repair with precision tools like hydrogels, stem cells, and bioengineered scaffolds. Chronic wounds cost Medicare an estimated $22.5 billion annually, making these innovations both scientifically vital and economically urgent. Explore how this rapidly growing field is learning to restart the body’s own healing symphony.
Cell Therapy Review 2026: Mechanisms, Evidence & the Evolving Landscape
Cell therapy has evolved into one of medicine’s most consequential frontiers, with over 10,000 clinical trials active worldwide in 2026. This comprehensive cell therapy review maps every major modality—from CAR-T and NK cells to mesenchymal stem cells—alongside the autoimmune breakthroughs and regulatory shifts redefining the field. From a market valued at $8.85 billion today to a projected $55.72 billion by 2035, the landscape has never moved faster.